Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Aliment Pharmacol Ther. 2013 May 29;38(2):10.1111/apt.12352. doi: 10.1111/apt.12352

Table 2.

ALT responses and changes in histological features

Vitamin E
Placebo
Histological feature ALT R* (n = 34) ALT NR* (n = 37) P value ALT R* (n = 11) NR* (n = 57) P value
Mean change in steatosis score −1.1 −0.4 <0.001 −0.7 −0.0 <0.001
Mean change in inflammation score −1.1 −0.3 <0.001 −0.5 −0.2 0.14
Mean change in Ballooning score −0.8 −0.2 0.01 −0.5 −0.2 0.42
Mean change in NAS score −3.0 −0.8 <0.001 −1.6 −0.4 0.03
Mean change in Fibrosis score −0.5 −0.2 0.34 −0.8 −0.0 0.04
Decrease in NAS by ≥2 points 82% 32% <0.001 55% 25% 0.07
Resolution of NASH 44% 22% 0.07 45% 14% 0.03
Mean change in Weight (kg) −0.9 1.8 0.03 −3.7 1.8 0.01
*

ALT R = response defined as decrease to 40 U/L or less and by 30% or more from baseline. ALT NR = lack of ALT response.

Total non-alcoholic fatty liver activity score (NAS), comprising the sum of scores for steatosis, inflammation and ballooning cell injury.

Resolution of histological features that fulfil the criteria for diagnosis of non-alcoholic steatohepatitis (NASH).